SolasCure ploughs ahead with maggot-derived wound gel after positive phase 2 results
SolasCure is moving forward with its maggot-derived wound gel, after publishing the results of its recent phase 2 clinical trial in a leading wound care journal.
Archives for March 4, 2024
Early pancreatic cancer diagnosis could be possible with ‘groundbreaking’ new blood test
California-based biotech company Metabolomycs has released a new study demonstrating how pancreatic cancer could be diagnosed earlier with a blood test.
Biogen relying on success of Leqembi following discontinuation of Aduhelm
Biogen’s stance at the upcoming AD/PD 2024 International Conference on Alzheimer’s disease and Parkinson’s disease will demonstrate its future plans for treating Alzheimer’s, following the discontinuation of Aduhelm (aducanumab), its anti-amyloid beta...